Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.

Background Cryptococcosis is a leading cause of death among people with human immunodeficeincy virus (HIV). Guidelines recommend combination therapy with amphotericin B and flucytosine, but standard flucytosine dosing of 100 mg/kg/day is associated with hematologic toxicity. The FLOOR trial investig...

Descripción completa

Detalles Bibliográficos

Publicado en:	Clinical Infectious Diseases Vol. 82; no. 1; pp. 67 - 75
Autores principales:	Rutakingirwa, Morris K, Skipper, Caleb P, Dai, Biyue, Wele, Abduljewad, Namombwe, Suzan, Mugabi, Timothy, Ndyetukira, Jane Frances, Sadiq, Alisat, Kabahubya, Mable, Chemusto, Lenard
Formato:	clinical trial research tables/charts Journal Article
Publicado:	Oxford University Press / USA 1/15/2026
Acceso en línea:	Ver este registro en EBSCOhost